Comparison between Auro Impex IPO and Remus Pharmaceuticals IPO.
Auro Impex IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Remus Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
Auro Impex IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Bookbuilding | Bookbuilding |
Listing At | NSE SME | NSE SME |
Lead Managers | Affinity Global Capital Market Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
Registrar | Cameo Corporate Services Ltd. | MUFG Intime India Pvt.Ltd. |
Market Maker | Rikhav Securities Ltd. | Sunflower Broking Pvt.Ltd. |
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | RHP ![]() |
Anchor Investor | Anchor Investor ![]() | |
IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of Auro Impex IPO is up to ₹25.71 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹45.29 Cr. The final issue price of Auro Impex IPO is ₹78.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.
Auro Impex IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹74.00 per share | ₹1,150.00 per share |
Issue Price (Upper) | ₹78.00 per share | ₹1,229.00 per share |
Issue Price (Final) | ₹78.00 per share | ₹1,229.00 per share |
Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
Discount (Employee) | ||
Market Lot Size | 1600 shares | 100 shares |
Fresh Issue Size | 27,45,600 shares | 3,68,500 shares |
Fresh Issue Size (Amount) | up to ₹21.42 Cr | up to ₹45.29 Cr |
OFS Issue Size | 5,50,400 shares | 0 shares |
OFS Issue Size (Amount) | up to ₹4.29 Cr | up to ₹0.00 Cr |
Issue Size Total | 32,96,000 shares | 3,68,500 shares |
Issue Size Total (Amount) | up to ₹25.71 Cr | up to ₹45.29 Cr |
Auro Impex IPO opens on May 11, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Auro Impex IPO and Remus Pharmaceuticals IPO is May 15, 2023, and May 19, 2023, respectively.
Auro Impex IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Anchor Bid Date | May 16, 2023 | |
Issue Open | May 11, 2023 | May 17, 2023 |
Issue Close | May 15, 2023 | May 19, 2023 |
Basis Of Allotment (Tentative) | May 18, 2023 | May 24, 2023 |
Initiation of Refunds (Tentative) | May 19, 2023 | May 25, 2023 |
Credit of Share (Tentative) | May 22, 2023 | May 26, 2023 |
Listing date (Tentative) | May 23, 2023 | May 29, 2023 |
Anchor Lockin End date 1 | Jun 23, 2023 | |
Anchor Lockin End date 2 | Aug 22, 2023 |
Auro Impex IPO P/E ratio is 12.07, as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.
Auro Impex IPO | Remus Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.99 | 92.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 68.37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 12.07 | 21.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹95.17 Cr. | ₹181.03 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 71.44% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 69.99% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 2.77 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹6.00 | ₹33.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 19.92% | 52.64% |
In the Auro Impex IPO Retail Individual Investors (RII) are offered 18,46,400 shares while in Remus Pharmaceuticals IPO retail investors are offered 18,46,400 shares. Qualified Institutional Buyers (QIB) are offered 3,29,600 shares in Auro Impex IPO and 73,700 shares in Remus Pharmaceuticals IPO.
Auro Impex IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Anchor Investor Reserveration | 1,10,500 shares | |
Market Maker Reserveration | 1,74,400 shares | 19,500 shares |
QIB | 3,29,600 shares | 73,700 shares |
NII | 11,20,000 shares | 55,300 shares |
RII | 18,46,400 shares | 1,29,000 shares |
Employee | ||
Others | ||
Total | 32,96,000 shares | 3,68,500 shares |
Auro Impex IPO subscribed 66.94x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.
Auro Impex IPO | Remus Pharmaceuticals IPO | |
---|---|---|
QIB (times) | 31.67x | 10.75x |
NII (times) | 104.05x | 229.31x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 50.72x | 49.81x |
Employee (times) | ||
Other (times) | ||
Total (times) | 66.94x | 57.21x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O